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Abstract
Background: Genetically engineered mouse models of mammary gland cancer enable the in vivo
study of molecular mechanisms and signaling during development and cancer pathophysiology.
However, traditional whole mount and histological imaging modalities are only applicable to non-
viable tissue.
Methods: We evaluated three techniques that can be quickly applied to living tissue for imaging
normal and cancerous mammary gland: reflectance confocal microscopy, green fluorescent protein
imaging, and ultrasound imaging.
Results: In the current study, reflectance confocal imaging offered the highest resolution and was
used to optically section mammary ductal structures in the whole mammary gland. Glands
remained viable in mammary gland whole organ culture when 1% acetic acid was used as a contrast
agent. Our application of using green fluorescent protein expressing transgenic mice in our study
allowed for whole mammary gland ductal structures imaging and enabled straightforward serial
imaging of mammary gland ducts in whole organ culture to visualize the growth and differentiation
process. Ultrasound imaging showed the lowest resolution. However, ultrasound was able to
detect mammary preneoplastic lesions 0.2 mm in size and was used to follow cancer growth with
serial imaging in living mice.
Conclusion: In conclusion, each technique enabled serial imaging of living mammary tissue and
visualization of growth and development, quickly and with minimal tissue preparation. The use of
the higher resolution reflectance confocal and green fluorescent protein imaging techniques and
lower resolution ultrasound were complementary.
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Background
Transgenic mouse models have been developed to recapit-
ulate the complex effects of genes known to be involved
in human breast cancer. These models can help to eluci-
date the mechanism of action of these genes during car-
cinogenesis, as well as their impact on normal mammary
gland development. Imaging methods for mouse models
of normal and cancerous mammary glands are in the
developing stages and can help in the search for better
ways to diagnosis human breast cancer earlier [1].
In order to study early phenotypic effects of gene over-
expression or lack of expression on mammary gland
development and cancer traditional methods require that
tissue is harvested from the animal and subjected to histo-
logical techniques to detect morphologically aberrant
growth. These invasive procedures preclude further exam-
ination of the effects of these genetic changes on the proc-
ess of carcinogenesis. Later, once the tumor becomes
palpable, the size of the developing tumor can be meas-
ured and followed in vivo over time to determine prolifer-
ative capacity. However, no information about initiation
and progression can be gathered; only at the end of the
experiment [2] can information about the morphology or
gene expression profile of the developing tumor be
obtained.
The implementation of in vivo imaging modalities to
study normal mammary gland growth and disease pro-
gression has greatly improved the utility of these models,
allowing the study of mammary differentiation or disease
process, not simply the final effect [3]. Biochemical and
morphologic changes associated with early cancer change
the optical properties of tissue, especially the absorption,
scattering, and fluorescence, allowing the detection of
these early carcinogenic effects with optical spectroscopy
techniques [4]. Imaging can allow researchers to, with
minimal invasiveness, detect and follow abnormalities in
ductal development during mammary differentiation in
the same living animal. In cancer studies, imaging can
detect undissected preneoplastic lesions and follow the
behavior of these cancer cells, interactions with their stro-
mal environment during the development of a tumor,
angiogenesis, and metastatic disease. This can all be stud-
ied over time in the context of the cancer cells own physi-
ological environment with an intact blood supply and
interaction with surrounding tissues in 3-D and in real-
time [1,5,6]. Imaging regimens can also be adapted to
evaluate efficacy and response of a cancer to prevention
and therapeutic interventions [7,8] and to detect the pres-
ence of chemoresistance [9]. Serial minimally invasive
imaging of mice reduces the number of mice needed per
experiment or in preclinical drug development since mul-
tiple time points can be observed in the same animal [8].
The imaging modalities reflectance confocal microscopy
(RCM), green fluorescent protein (GFP) imaging, and
ultrasound imaging were utilized in this paper to image
mammary glands and mammary tumors.
RCM provides real-time minimally invasive 3-D section-
ing of in vivo (living) or ex vivo (newly biopsied) individ-
ual cells and tissues using variations in the optical
properties of the natural backscattering of light from dif-
ferent cellular and subcellular structures without the use
of labeling cells fluorescently or otherwise [10,11]. Opti-
cal techniques such as RCM have demonstrated high sen-
sitivity for detecting cancer in their natural environment
without using ionizing radiation [12] and without time-
consuming and potentially destructive fixation and stain-
ing, both of which may introduce artifacts and damage tis-
sue [13]. Tissue studied with RCM is treated with acetic
acid, which induces DNA condensation providing
increased reflectance to contrast nuclear versus cytoplas-
mic structure. We have shown that tissue treated with ace-
tic acid can then be subjected to histological and
immunohistological analyses without detrimental effects
on the tissue [14], facilitating further study into signaling
pathways which may be active in the imaged structure
[15]. RCM has been performed on biopsy specimens to
assess tumor margins [16] and to identify precancerous
lesions in human breast core needle biopsies [14], the cer-
vix [17], and skin [18].
Fluorescent protein labeling and epi-illumination spec-
troscopy microscopy are very powerful tools to follow pri-
mary tumor growth and metastasis with fluorophores in
vivo and in real time [19]. Transgenic GFP optical imaging
is one type of fluorescent protein label imaging and
involves the detection of reporter transgene expression,
namely a genetically encoded fluorescent protein, which
is utilized to image cells within living tissue [3,20]. The
specimen, often exposed surgically, is illuminated with
blue light (488 nm excitation wavelength) which is
absorbed by green fluorescent protein, a protein originally
from the jellyfish Aequorea Victoria [6]. GFP then emits
green light (509 nm peak shifted emission wavelength)
which is collected by CCD cameras [21]. GFP imaging can
be used as a cell marker in both the living animal and in
tissue culture and does not require a substrate for visuali-
zation [22].
GFP transfected tissue culture cells and GFP transgenic
mice have been used to monitor real time tumor growth
and for mechanistic studies [23,24], evaluate the efficacy
of therapy in a tumor xenograft model with metastasis
[25], monitor specificity of in vivo gene therapy studies
[26], mark and sort potential mammary stem cells [27],
and examine mammary epithelial tumor cell behavior in
metastasis [28]. In addition to monitoring mammary
gland development on the whole at the ductal morphol-BMC Cancer 2008, 8:21 http://www.biomedcentral.com/1471-2407/8/21
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ogy level as in our current study, GFP can be used to image
single cells. This high resolution GFP imaging of cells in
vivo has been combined in a dual labeling approach with
red fluorescent protein (RFP) to monitor tumor-stroma
interactions and drug response of cancer and stromal cells
[29,30].
Ultrasound imaging involves exposing tissues to high-fre-
quency ultrasound waves (20–60 MHz in animals; 2–10
MHz in humans) by placing a transducer (which contains
crystals that vibrate when exposed to small electrical cur-
rents and produce sound waves) on the skin and then
detecting the ultrasound reflections from internal organs
under investigation [6,31,32]. This non-invasive tech-
nique produces a dynamic real-time image of the tissue
from which structural and functional information can be
obtained because sound waves travel though soft tissue
based on the acoustic impedance of each tissue, which is
a function of the tissue density [31]. When two tissues
with different densities are next to each other, a mismatch
in the acoustic impedance causes sound waves to be
reflected relative to the degree of mismatch; a greater
acoustic impedance mismatch leads to a greater reflected
pressure magnitude or intensity and is seen as a brighter
image [31].
Ultrasound is a rapid non-radiation method that has been
used to detect cystic masses [33] and superficial tumors
[34], differentiate between fibroadenomas and carcino-
mas in animal models [35], noninvasively track liver
metastases growth and evaluate potential therapy in liver
metastasis models [36], measure blood flow by Doppler
[37,38], guide biopsy of a palpable breast mass [38], and
guide injections into target organs [39].
In the present study, we use RCM, GFP, and ultrasound to
visualize mammary gland and mammary tumor charac-
teristics in vivo. We show that RCM can be used to study
mammary development in an ex vivo whole organ culture
setting with good resolution using a lower concentration
of acetic acid. We show that GFP expression can be used
to visualize mammary gland ducts, mammary tumor, and
tumor vasculature, to follow lobuloaveolar development
in an ex vivo whole organ culture experiment, and can be
used to follow development of transplanted mammary
glands. We show that ultrasound imaging can be used to
visualize normal mammary gland, hyperplastic areas of
preneoplasia, to follow tumor progression and liver
metastases, and can be used to distinguish between mam-
mary tumor and enlarged lymph node. In conclusion, we
show that these modalities are, individually and in com-
bination, useful in studying normal and carcinogenic bio-
logical processes in the mouse mammary gland
longitudinally and with minimal invasiveness.
Methods
Mouse Models, Mammary Gland Whole Mounts, and 
Hematoxylin and Eosin Sections
Mammary glands from wild-type C57Bl/6 female mice,
female mice from a model of Estrogen Receptor alpha
(ERα) driven mammary cancer (tTA/TAg/ERα mice) [40],
and female mice from a WAP-TAg mammary cancer
model [41] were examined by different imaging modali-
ties in this study. In general, after imaging was performed,
one #4 mammary gland was fixed in formalin overnight,
embedded in paraffin, slices (5 µm) mounted on glass
slides, and stained with Hematoxylin and Eosin (H&E).
For mammary gland whole mount staining, the other #4
mammary gland was fixed in Carnoy's fixative and stained
in Carmine-alum as previously described [42]. Visualiza-
tion of carmine-alum and H&E stained mammary glands
was performed on an Eclipse E800M microscope (Nikon
Instruments Inc., Melville, NY, USA). Mammary gland
preneoplastic lesions were measured in situ upon
necropsy to compare with measurements taken with the
ultrasound software (n = 7). For the metastasis study, the
primary mammary adenocarcinoma was removed at 10
months of age. Two weeks after the tumor was removed
mammary glands and liver were imaged with ultrasound
to screen for the development of new tumors and liver
metastases. The mouse was euthanized at 12 months of
age because of difficulty breathing and unresponsiveness,
1 month after the original ultrasound and before a second
scheduled ultrasound could take place. The presence of
liver, lung and omental metastases were confirmed on
necropsy. All procedures involving animals were per-
formed in accordance with current federal (National Insti-
tutes of Health Guide for the Care and Use of Laboratory
Animals) and University guidelines and were reviewed
and approved by the Georgetown University Institutional
Animal Use and Care Committee.
Reflectance Confocal Microscopy
Mammary gland ductal and epithelial cell morphology
from non-pregnant wild-type mice were directly imaged at
different stages of development by reflectance confocal
microscopy using the VivaCell 5000 Reflectance Confocal
Microscope (VivaCell-TiBa, Rochester, NY, USA) with a
30× water immersion lens. Mice were euthanized prior to
reflectance confocal imaging. Upon necropsy, the #3
mammary glands were injected with a dilute (5%) acetic
acid in phosphate buffered saline (PBS) solution as a con-
trast agent to enhance visualization of the nuclei within
cells by promoting condensation of nuclear material
[43,44]. The mammary gland was then dissected and
spread on the microscope stage above the objective on the
Vivacell 5000 and images (originally 500 µm × 500 µm)
were taken with the VS2000ui imaging software (version
vs006.00.11, Lucid, Inc., Rochester, NY), as described pre-BMC Cancer 2008, 8:21 http://www.biomedcentral.com/1471-2407/8/21
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viously [15,45]. After imaging, the mammary glands were
fixed in formalin for H&E staining as described above.
GFP Imaging
Transgenic tTA/TAg/ERα mice were bred to mice carrying
the enhanced Green Fluorescent Protein (GFP) transgene
under the control of the chicken beta-actin promoter cou-
pled with the cytomegalovirus (CMV) immediate early
enhancer (FVB.Cg-Tg(ACTB-EGFP)B5Nagy/J strain from
The Jackson Laboratories, Bar Harbor, Maine).
These mice express GFP in all cells of the mouse express-
ing actin, especially in the skin and mammary glands [20].
Due to the nature of adipocytes having low fluorescence,
even though they do express GFP, the mammary ductal
tree was easily visualized in contrast to the less bright fat.
The Nikon SMZ-1500 EPI-Fluorescence Digital Stereo-
scope System (Melville, NY) was used to visualize GFP-
expressing mammary gland and mammary tumor tissues
and pictures were taken with the Metamorph imaging
software (Molecular Devices Corp, Sunnydale, CA). Using
the Apo 1× objective with the 10× eyepiece, the Nikon
SMZ-1500 EPI-Fluorescence Digital Stereoscope System
has a field of view between 29.3 mm for the 0.75× zoom
and 2.0 mm for the 11.25× zoom.
For the in vivo GFP experiment, a 4-week-old GFP mouse
was anesthetized and incisions made in the abdominal
skin such that the skin could be folded back to allow
imaging of the ductal epithelial tree in the #4 mammary
gland. After images were acquired as above, the skin was
closed with surgical staples and the mouse was allowed to
recover. At 8 weeks of age the mouse was euthanized and
both #4 mammary glands harvested, placed on glass
slides, and imaged by GFP fluorescence.
Mammary Gland Whole Organ Culture
Mammary gland whole organ culture (WOC) was carried
out essentially as previously described [46]. Briefly, 21–24
day old wild-type female mice were anesthetized and sub-
cutaneously implanted in the interscapular area with a 21-
day release 0.01 mg 17β-estradiol and 10 mg progesterone
(E&P) pellet (Innovative Research of America, Sarasota,
Florida) to prime the mammary glands for WOC. After 14
days of priming, the mice were sacrificed and the #4 mam-
mary glands were harvested, placed on a square of cotton
mesh and floated in WOC growth phase media, Way-
mouth's MB 752/1 media (Biosource Biofluids, Rockville,
MD) supplemented with Antibiotic-Antimycotic (Gibco/
Invitrogen, Grand Island, NY), insulin (5 µg/ml), prolac-
tin (1 µg/ml), aldosterone (0.1 µg/ml), hydrocortisone
(0.1 µg/ml) (IPAH). Glands were incubated at 50% oxy-
gen, 5% CO2 in humidified air at 37°C (Heraeus Instru-
ments, Newtown, CT).
A WOC experiment was performed to test viability of the
mammary glands after treatment with acetic acid and vis-
ualization with RCM. Mammary glands of three-week-old
wild-type female mice were primed with an E&P pellet as
described above. After 14 days of priming, the mice were
sacrificed and mammary glands #3 and #4 were har-
vested. One gland was immediately placed in IPAH WOC
media. Before placing the other mammary glands in
WOC, they were treated with PBS, 1, 3, or 5% acetic acid
in PBS (3 mammary glands per treatment) and were
imaged with RCM. After imaging for no more than 5–10
minutes, the mammary glands were placed in IPAH media
as described above. After seven days in culture (post-
WOC), the #4 mammary glands were whole mounted and
#3 mammary glands were fixed and H&E stained as
described above. RCM images from mammary glands
treated with PBS or acetic acid pre-WOC were compared
with the whole mounts and H&E slides post-WOC.
For the WOC GFP images, the mammary glands from
mice expressing GFP alone were treated with IPAH for 10
days. Each day, the mammary glands were visualized with
GFP imaging to detect and follow changes and growth in
the ductal tree.
Ultrasound
Mice were anesthetized by inhalation of isoflurane with
1–3% oxygen and ventral hair was removed using a mild
depilatory cream. Mice were placed on a thermostatically
controlled heating pad to help maintain mouse body tem-
perature. A water based ultrasonic gel was applied
between the imaging probe transducer and the mouse
skin and the liver, mammary tumors, and all ten mam-
mary glands from a total of 16 wild-type, tTA/TAg/ERα,
and WAP-TAg mice were imaged with the Visualsonics
Vivo 660 High-Resolution Imaging System for small ani-
mal ultrasound (Toronto, Ontario, Canada). Transducers
were 55 MHz for mammary gland and 40 MHz for liver
imaging. Orientation of the mammary gland on ultra-
sound was accomplished by visualizing the lymph node,
which is less echogenic and appears as a black hole sur-
rounded by the echogenic mammary gland tissue. Mam-
mary gland preneoplastic lesions were measured with the
ultrasound software using acquired images in the plane
showing the largest cross-sectional area of each lesion.
These ultrasound measurements were compared with
measurements taken at necropsy (n = 7).
Mammary Gland Transplantation
Mammary gland transplantation is a useful technique to
study the specific effects of hormone or even genetic influ-
ences on mammary gland growth, differentiation, and
carcinogenesis. Unfortunately, it is not always possible to
distinguish whether the transplanted mammary gland
grew or if it was actually the host mammary gland. Some-BMC Cancer 2008, 8:21 http://www.biomedcentral.com/1471-2407/8/21
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times the host mammary gland does grow even if the fat
pad of the host is cleared of epithelial cells, which should
ensure that the host mammary gland cannot grow. In
order to definitively determine the mammary gland of ori-
gin and therefore a successful versus unsuccessful mam-
mary gland transplantation, mammary glands from GFP
expressing mice were transplanted into non-GFP express-
ing hosts. If the mammary gland that grew expressed GFP,
then the mammary gland was from the transplanted
mammary gland (GFP positive). If the mammary gland
that grew did not express GFP, then it was residual host
mammary gland (GFP negative). Both #4 mammary
glands from 1 to 2-day-old newborn female and male
pups were removed under a dissecting stereomicroscope
(Zeiss Stemi SV 11, Germany) and placed in a culture dish
containing DMEM:Ham's F-12 (1:1) with 10% fetal calf
serum, 2 mM glutamine and 1% penicillin-streptomycin
to keep the glands moist and maintain tissue viability
before transplantation. The mammary glands were then
transplanted into 3- to 4-week-old female nude mice
without clearing the mammary fat pad: an incision was
made and a pocket was created between the #3 and #4
mammary glands in the nude mouse and both mammary
glands from the newborn pups were introduced in the
pocket [47]. Post-transplantation, a cohort of the host
mice were housed with males to become pregnant. Mice
that were not housed with males were euthanized 8 weeks
after transplantation. For the studies of pregnant trans-
planted mammary gland, mice that became pregnant were
euthanized during late pregnancy (17–19 days preg-
nancy). For both cohorts, the transplanted glands were
removed at necropsy, imaged for GFP expression as
described above, and then whole mounted for morpho-
logical studies.
Results and Discussion
Imaging mammary ductal structure using reflectance 
confocal microscopy
Details of mammary ductal structure primary (Figure 1A
and 1B), secondary (Figure 1E,F,G,H,I, and 1P) and terti-
ary branching (Figure 1J,K,L, and 1M), terminal end buds
(Figure 1C and 1D), lobules (Figure 1N and 1O) and duc-
tal ectasia (Figure 1Q) are readily visualized using reflect-
ance confocal imaging. A 3-D rendering of terminal end
bud structures is included as Additional File 1. To deter-
mine if this technique could be used to visualize structural
elements prior to whole mammary organ culture, we
treated mammary glands from E&P pellet primed five-
week-old mice with PBS, 1%, 3%, or 5% acetic acid,
imaged the gland with RCM, and then subjected them to
WOC media supplemented with IPAH for 1 week. Quality
of RCM images pre WOC (Figure 2 left column) were
compared with the quality of whole mount (WM) and
H&E obtained post WOC (Figure 2 middle and right col-
umns). In the absence of acetic acid (PBS alone), ductal
structures could not be distinguished in the RCM image
(Figure 2D). One percent acetic acid was sufficient for vis-
ualization of terminal end bud structures, which were eas-
ily distinguishable with RCM because of their well-
defined tear-drop shaped structure (Figure 2G) compared
to non-imaged glands (Figure 2A), although image con-
trast, i.e. ability to distinguish individual cells in the mul-
tiple cell layers of the terminal end bud, was improved
with 3% acetic acid (Figure 2J) and 5% acetic acid (Figure
2M). However, only the glands treated with 1% acetic acid
were able to grow consistently and differentiate normally
in response to IPAH in whole organ culture (Figure 2H
and 2I) as compared to the non-imaged glands immedi-
ately put into culture (Figure 2B and 2C) and imaged
glands treated with PBS alone (Figure 2E and 2F). Glands
imaged with 3% acetic acid showed a partial viable
response (Figure 2K and 2L), while no clear response was
found in glands treated with 5% acetic acid (Figure 2N
and 2O). In conclusion, RCM imaging using 1% acetic
acid allows adequate visualization of ductal morphology
while preserving the viability of the gland.
Imaging alveolar, ductal, and tumor mammary 
development using GFP fluorescence
GFP imaging of the whole mouse mammary gland (Figure
3A and 3C) allows for visualization with similar detail of
ductal development as a whole mount (Figure 3B and 3D)
even without the fat pad dissolution that occurs during
whole mount fixation. Mammary tumors appear less
bright when in the same field as brighter mammary ducts
(Figure 3E) and homogeneously brighter when in the
same field as tumor associated blood vessels which dis-
play reduced fluorescence (Figure 3F–H). Neovasculariza-
tion of primary tumors can be imaged because the
nonluminous angiogenic blood vessels are in sharp con-
trast to the brightly fluorescent tumor [24,48]. Lymph
nodes (Figure 3I) can also be well appreciated when not
in a field with brighter mammary ducts (Figure 3K)
although not in as great detail as can be appreciated with
the H&E section of a lymph node (Figure 3J).
To establish whether the GFP imaging technique could be
accomplished in conjunction with in vivo methods, we
performed three mammary gland manipulations: whole
organ culture, mammary gland transplantation, and in
vivo surgical exposure. For the whole organ culture exper-
iment, glands from GFP expressing mice were harvested
and then imaged for Day 0 GFP fluorescence (Figure 4A).
After imaging, the glands were exposed to IPAH media in
culture and then imaged periodically for a total of 10 days
(Figure 4B–D). Increasing amounts of GFP fluorescence
shows that the alveolar development in response to the
IPAH stimulation can be followed in vivo. Similarly, mam-
mary glands from newborn GFP expressing mice (Figure
4E and 4F) were transplanted into nude mice.  GFPBMC Cancer 2008, 8:21 http://www.biomedcentral.com/1471-2407/8/21
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Reflectance confocal microscopy (RCM) can visualize ductal epithelial cells during mammary gland development, growth, and  aging Figure 1
Reflectance confocal microscopy (RCM) can visualize ductal epithelial cells during mammary gland develop-
ment, growth, and aging. Prominent features distinguishable with RCM are (A-B) rudimentary primary ductal trees (open 
arrowheads), (C-D) terminal end buds (closed arrowheads), (E-I, P) secondary branching (thin arrows), (J-M) tertiary 
branching (open arrows), (N-O) lobules (thick arrows), (Q) ductal ectasia or enlarged ducts (^). Magnification: 30×.
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RCM can image living tissue from mammary whole organ culture (WOC) Figure 2
RCM can image living tissue from mammary whole organ culture (WOC). Mammary glands from mice primed with 
an E&P pellet were either whole mounted immediately (uncultured) (A) or exposed to culture in IPAH supplemented media 
immediately (B-C). Other glands were put into IPAH culture after RCM imaging which was accomplished by injection with 
either PBS (D-F), 1% acetic acid (G-I), 3% acetic acid (J-L), or 5% acetic acid (M-O). Pre-WOC RCM images (D, G, J, M) 
display examples of terminal end buds which can be compared to the whole mount (WM) image (A). Alveolar development in 
the glands can be compared in post-WOC WM (B, E, H, K, N) and H&E (C, F, I, L, O) images. Arrowhead: terminal end 
bud, arrows: alveolar development, *: lymph node. Magnifications are as indicated.
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GFP imaging can reveal details of ductal development, mammary tumors, tumor associated blood vessels, and lymph node mor- phology Figure 3
GFP imaging can reveal details of ductal development, mammary tumors, tumor associated blood vessels, and 
lymph node morphology. Ductal development can be compared with two imaging techniques – by first GFP imaging the 
mammary gland (A, C) and then whole mounting the same gland (B, D). Mammary tumors appear less bright compared to the 
mammary ducts (E) and more bright compared to tumor associated blood vessels (F-H). Lymph nodes (I) can be highlighted 
close to brighter mammary ducts (K). (J) H&E section of a lymph node. Arrows: mammary ducts, ^: mammary tumor, open 
arrowheads: blood vessels, *: lymph node. Magnifications are as indicated.
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GFP fluorescence monitors ductal and alveolar development in WOC and during mammary gland transplantation Figure 4
GFP fluorescence monitors ductal and alveolar development in WOC and during mammary gland transplan-
tation. (A-D) Mammary glands were cultured in IPAH media for a total of 10 days. On days 0 (A), 3 (B), 7 (C), and 10 (D) 
the mammary glands were briefly removed from the incubator to examine alveolar development as visualized with GFP expres-
sion. (E-L) Mammary glands from newborn mice expressing GFP were transplanted into nude mice. E and F show the new-
born mammary gland pre-transplantation GFP and H&E imaging, respectively. Post-transplantation in a non-pregnant nude 
mouse (G-I) allows for visualization of ductal development of the transplanted gland as it grows to fill its fat pad whereas trans-
plantation from a pregnant nude mouse (J-L) causes the transplant to display lobular development characteristic of late preg-
nancy. GFP images: G and H (higher power) and J and K (higher power), Whole mount images: I and L. Arrows: mammary 
ducts, thick arrows: lobules, ^: nipple. Magnifications are as indicated.
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expression was appreciated in the resulting mammary
ductal development in transplants from non-pregnant
host nude mice (Figure 4G and 4H) and in the lobular
development in transplants from pregnant host nude
mice (Figure 4J and 4K).  Both compare well to non-preg-
nant and pregnant whole mounts (Figure 4I and 4L,
respectively). For the in vivo exposure experiment, a 4-
week-old GFP expressing mouse was anesthetized and
one #4 mammary gland exposed in vivo and imaged. The
lymph node, mammary ducts extending from the nipple,
and terminal end buds were clearly visible by GFP fluores-
cence (Figure 5A and 5B). After imaging, the mouse was
allowed to recover. Both #4 mammary glands were dis-
sected 4 weeks after in vivo exposure and showed a similar
degree of mammary development by GFP imaging (Figure
5C and 5D) indicating that surgical exposure and imaging
of the mammary gland did not alter its development.
Imaging non-palpable mammary gland lesions using 
ultrasound
Normal mammary gland demonstrates a relatively
homogenous echogenic imaging pattern (Figure 6A) with
Surgical exposure of the mammary gland for GFP imaging does not inhibit subsequent gland development Figure 5
Surgical exposure of the mammary gland for GFP imaging does not inhibit subsequent gland development. A 
4-week-old GFP mouse was anesthetized and one #4 mammary gland exposed in vivo and imaged. The epithelial tree is clearly 
visible, branching out from the nipple (^). (A) The lymph node (*) is visible at the junction of the blood vessels (open arrow-
heads). The dark crescent below the lymph node is caused by the mammary fat pad blocking the fluorescence of the underlying 
skin. (B) Two terminal end buds (marked with a box in panel A), at high magnification. After images were acquired the skin 
was closed and the mouse was allowed to recover. At 8 weeks of age the mouse was sacrificed and both #4 mammary glands 
were imaged for GFP fluorescence (C-D). Both glands show a similar degree of mammary development. Arrows: mammary 
ducts, open arrowheads: blood vessels, closed arrowheads: terminal end buds, *: lymph node, ^: nipple. Magnifications are as 
indicated.
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Ultrasound can detect nonpalpable lesions in the mammary gland of transgenic mice Figure 6
Ultrasound can detect nonpalpable lesions in the mammary gland of transgenic mice. (A) Fourth mammary gland 
ultrasound image from a control wild-type mouse illustrating the homogeneous texture of the mammary gland tissue that sur-
rounds the centrally located lymph node (*) with lines indicating the border of the #4 mammary gland. (B) Ultrasound image of 
the left #4 mammary gland of a tTA/TAg/ERα mouse with nonpalpable mammary lesions (thick arrows). The dense (less echo-
genic) tissue represents an area of increased cell number in the tTA/TAg/ERα mammary gland and correlates with the pres-
ence of hyperplastic alveolar nodules (HANs) identified after carmine-alum whole mount staining of the same mammary gland 
at necropsy (C). Image: 0.5×, insert: 4×. Thick arrows: HANs, white (ultrasound) or black (whole mount), thin white arrows: 
skin surface, *: lymph node. Scale for all ultrasound images: in mm. (D) Correlation between 2-D ultrasound and 3-D in situ 
measurements of mammary preneoplasias (n = 7 mice); R = 0.96, p < 0.001.
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Ultrasound can distinguish between different lesions in transgenic mice in vivo Figure 7
Ultrasound can distinguish between different lesions in transgenic mice in vivo. Possible applications are to identify 
and follow mammary tumor development and progression over time (A-C) and compare to the appearance of tumor at time 
of necropsy (D), identify liver metastasis (E-F), distinguish between adenocarcinoma (G) and enlarged lymphnodes (H). Thin 
white arrow: skin surface, thin black arrow: mitotic figure, thick white arrows: liver metastases, circle and black arrow: dis-
sected metastatic lesion, open white arrow: tumor, *: enlarged lymph node. Scale for all ultrasound images in mm.
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ultrasound. Lymph nodes (*) within the gland can be dis-
tinguished from surrounding gland structure. Similarly,
non-palpable preneoplastic mammary lesions can be vis-
ualized and distinguished from normal gland and lymph
node structure and size can be measured using ultrasound
imaging (Figure 6B). The less echogenic (dark spots,
arrows) preneoplastic lesions correlate well with hyper-
plastic alveolar nodules (HANs) observed on whole
mount (Figure 6C–D). While detailed ductal and cellular
structure cannot be appreciated with ultrasound, preneo-
plastic lesions can be followed over time to establish
growth rates of mammary tumor development (Figure
7A–D). Serial ultrasound was performed to image the
growth of a mammary adenocarcinoma over time from a
tTA/TAg/ERα mouse at 6 (A), 7 (B), and 8 (C) months of
age as compared to the appearance of the tumor at the
time of necropsy (D).  Using ultrasonography we were
able to detect mammary preneoplastic lesions as small as
0.2 mm (with an area of 0.09 mm2) at least 1.5 to 2
months prior to becoming palpable. In addition, multiple
liver metastases from an 11-month-old tTA/TAg/ERα
mouse with a mammary adenocarcinoma were visualized
with ultrasound (Figure 7E) and compared to the meta-
static lesion dissected out from the liver (Figure 7F). Ultra-
sound also proved useful in identifying a 1-mm3 solid
mammary adenocarcinoma from a tTA/TAg/ERα mouse
(Figure 7G). Note the absence of internal echoes consist-
ent with relatively homogeneous tissue. Ultrasound can
also distinguish between an adenocarcinoma and an
enlarged (1.5- to 2-mm3) lymph node (Figure 7H) which
was adjacent to the #2 mammary gland of a tTA/TAg/ERα
mouse and was confirmed as a lymph node at necropsy.
Conclusion
The studies presented here compare the well-established
techniques of mammary gland whole mounting and
hematoxylin and eosin histology with RCM, GFP, and
ultrasound to study mammary gland and mammary
tumor development. RCM, GFP, and ultrasound are quick
techniques that do not require tissue processing for imme-
diate imaging of mammary gland structures. RCM has the
potential to advance screening and diagnosis, especially
for the early detection of a variety of precancerous lesions
[13,49-51]. We have shown here and previously that RCM
is very useful in optical serial imaging of normal mam-
mary gland ductal structures and tumors in harvested tis-
sues from genetically engineered mice [15]. It has a
resolution comparable to the ductal structure resolution
of a mammary whole mount and the cellular resolution of
mammary histology. This technique can be used for 3-D
reconstruction of MG morphology and can be used in liv-
ing tissue. In this study RCM was also used in combina-
tion with whole mammary gland organ culture.
Additional RCM applications include using it to excise
specific mammary structures for transplant studies. GFP
imaging is also useful for in vivo studies, as well as for
whole organ culture and transplantation, where it can be
used to follow development and/or disease progression.
GFP has been shown to be invaluable in mammary gland
transplantation studies where it can successfully answer
such questions as whether a growth factor acts in an auto-
crine or paracrine fashion during mammary gland devel-
opment by allowing for labeling and following the
development of specific mammary cells transplanted into
a fat pad [52]. Ultrasound demonstrates the least cellular
resolution and requires an experienced operator to obtain
consistent images, but is very useful for in vivo and non-
invasive imaging of development of non-palpable prene-
oplastic lesions into mammary adenocarcinomas. 3-D
ultrasound imaging software can be used to obtain direct
measurements of lesion volume, if needed. In summary,
all three techniques are valuable adjuvants to the study of
mammary development and cancer progression.
The imaging modalities used in this paper, RCM, GFP,
and ultrasound imaging, are just a few of the many tech-
niques being developed to study the mammary gland and
mammary cancer. These versatile techniques can be com-
bined with each other (i.e. fluorescence and RCM), as well
as with other techniques, such as those that involve the
detection of specific probes to image targeted cells while
simultaneously acquiring confocal contrast images to
localize the targeted cells within the histological context
of the tissue being imaged [53,54]. Combining these tech-
niques allows the researcher to obtain actual in vivo
molecular expression information from the image ena-
bling the study of the molecular basis of initiation and
progression of mammary cancer. All of these minimally
invasive techniques allow longitudinal imaging to pro-
vide complete and precise information about mammary
gland development, as well as, tumor initiation and pro-
gression in any transgenic cancer mouse model. The fur-
ther development of mouse imaging techniques may well
lead to the advancement of new technologies that can be
translated to more sensitively and specifically detect pre-
cancerous abnormalities, diagnose curable pre-cancerous
lesions, and to increase patient survival and quality of life
in breast cancer patients.
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